Eternygen GmbH

Key figures / Profile

• founded in June 2012
• is a project focused and virtual drug development company located at the Bayer CoLaborator
• R&D program is focused on the sodium coupled citrate transporter (NaCT), a novel target which is also known as INDY (I am Not Dead Yet)
• The company has successfully generated in-vivo proof of concept data with an early lead candidate in animal models. Lead optimization phase is ongoing.
• has a drug development collaboration with Evotec AG

We offer

• Sharing experiences and know-how in following fields: drug discovery, drug development, preclinical development, virtual drug development, CRO selection, metabolic diseases (in vitro and in vivo models), transporter biology, fund raising
• Broad network for CROs and VCs